References
1. Craven V, Hausdorff WP, Everard ML. High levels of inherent
variability in microbiological assessment of bronchoalveolar lavage
samples from children with persistent bacterial bronchitis and healthy
controls. Pediatric pulmonology 2020.
2. Denton M, Doherty C, Foweraker J, et al. Laboratory standards for
processing microbiological samples from people with cystic fibrosis.Cystic Fibrosis Trust; Report of the UK Cystic Fibrosis Trust
Microbiology Laboratory Standards Working Group: Kent, UK 2010.
3. Salter SJ, Cox MJ, Turek EM, et al. Reagent and laboratory
contamination can critically impact sequence-based microbiome analyses.BMC biology 2014; 12 : 87.
4. Hare KM, Pizzutto SJ, Chang AB, et al. Defining lower airway
bacterial infection in children with chronic endobronchial disorders.Pediatric pulmonology 2018; 53 (2): 224-32.
5. Rosenow T, Mok LC, Turkovic L, et al. The cumulative effect of
inflammation and infection on structural lung disease in early cystic
fibrosis. The European respiratory journal 2019; 54 (1).
6. Frayman KB, Armstrong DS, Carzino R, et al. The lower airway
microbiota in early cystic fibrosis lung disease: a longitudinal
analysis. Thorax 2017; 72 (12): 1104-12.